Clinical Efficacy Analysis of Augmentation Mammoplasty with Cell-Assisted Autologous Fat Transplantation

Objective To analyze the clinical efficacy of augmentation mammoplasty with cell-assisted autologous fat transplantation. Methods Thirty-four cases of micromastia patients in our hospital were randomly divided into control group (n = 17) and observation group (n = 17). Breast augmentation with autologous fat transplantation alone and cell-assisted autologous fat transplantation were performed, respectively, compare and observe the therapeutic effect. Results Compared with the control group, the effective rate of breast augmentation was higher in the observation group. After six months of treatment, the increase value of chest circumference (CC), Sternal notch-nipple distance (SN-N),distance between nipple and inframammary fold (N-MF) was higher in the observation group, and the uplift value was higher after six months surgery, with statistical significance (p < 0.05). MRI showed higher postoperative fat retention rate, QLQ-30 Quality of life scores showed no significant difference (p > 0.05).

Automated summary

This study analyzed the clinical efficacy of augmentation mammoplasty with cell-assisted autologous fat transplantation. The results showed that compared to traditional autologous fat transplantation, cell-assisted autologous fat transplantation provided better breast augmentation results with a higher postoperative fat retention rate.